Enhanced CD33 CAR-NK cells secreting anti-CD73scFv overcome adenosine-mediated immunosuppression and improve anti-AML efficacy

CD33 癌症研究 离体 免疫疗法 免疫学 嵌合抗原受体 医学 白细胞介素12 细胞毒性T细胞 细胞毒性 髓系白血病 免疫抑制 白细胞介素21 肿瘤微环境 细胞疗法 体内 NK-92 髓样 封锁 T细胞 髓源性抑制细胞 自然杀伤细胞 淋巴因子激活杀伤细胞 抗原提呈细胞 免疫系统 抗原 细胞 生物 白血病 干细胞 祖细胞 化学 造血 细胞培养
作者
Lu Wang,Sha Gong,Jun Wang,Yingying Bao,Nan Mei,Xiaohong Lu,Weiwei Chen,Lei Xi,Huanming Zhang,Xin Chen,Pengbo Ning,Xiaohu Fan,Huaiyu Wang
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:14 (9): e014825-e014825
标识
DOI:10.1136/jitc-2026-014825
摘要

BACKGROUND: Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with dismal outcomes, especially in relapsed/refractory settings. Chimeric antigen receptor natural killer (CAR-NK) cell therapy holds promise but is constrained by the immunosuppressive tumor microenvironment (TME), where adenosine-mediated suppression is a key barrier. OBJECTIVE: To develop a novel CAR-NK construct cotargeting AML cells and the adenosine-rich TME to enhance antileukemia efficacy. METHODS: Ex vivo expanded primary NK cells were used to compare the effects of CD39 versus CD73 blockade on NK cell function via messenger RNA-electroporated antibodies. A CD33-CD73 dual-function CAR-NK construct (integrating CD33-specific lysis and anti-CD73scFv secretion for TME disruption) was designed and transduced into NK cells via retrovirus. Engineered NK cells were characterized for transduction efficiency, expansion, purity, viability, and CAR stability. In vitro cytotoxicity against AML cell lines and primary blasts was assessed, and in vivo efficacy was evaluated in a MOLM-13 xenograft mouse model. RESULTS: CD73 blockade more potently enhanced NK cell activity than CD39 blockade. Retroviral transduction achieved >50% efficiency, and expansion with K562-4-1BBL-mbIL-21/-15 feeder cells yielded NK cells with ≥6,000 fold expansion, >93% purity, >98% viability, and stable CAR expression. At an effector-to-target ratio of 0.5:1, CD33-CD73 CAR-NK cells mediated ~80% specific lysis, with superior cytotoxicity vs conventional CD33 CAR-NK cells. In xenografts, CD33-CD73 CAR-NK cells achieved robust tumor clearance, extended median survival by 24.5 days (59.5 vs 35 days) versus standard CD33 CAR-NK cells, and five out of six mice achieved long-term survival (>50 days). CONCLUSION: The CD33-CD73 dual-targeting CAR-NK platform synergistically targets AML cells and the adenosine-rich TME, exhibiting superior anti-leukemia efficacy. This strategy advances AML immunotherapy and provides a translational blueprint for TME-targeted therapies in other cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
superZ完成签到,获得积分10
刚刚
郭天浩完成签到,获得积分10
刚刚
1秒前
李星云完成签到,获得积分10
1秒前
1秒前
HaohaoLi完成签到,获得积分10
2秒前
minkeyantong完成签到 ,获得积分10
2秒前
只只完成签到,获得积分10
2秒前
ZZU1997发布了新的文献求助10
2秒前
2秒前
YY发布了新的文献求助10
2秒前
研友_24789完成签到,获得积分10
2秒前
Janmy完成签到,获得积分10
3秒前
W10完成签到,获得积分10
3秒前
大个的应助被科研路顺遂采纳,获得10
3秒前
秋风的应助被幸福曼岚采纳,获得10
3秒前
完美萤发布了新的文献求助30
4秒前
4秒前
温婉的荷花完成签到,获得积分10
4秒前
初景发布了新的文献求助10
4秒前
夏歌蝉完成签到,获得积分10
5秒前
书写笔迹发布了新的文献求助10
5秒前
5秒前
干鞅完成签到,获得积分10
6秒前
邱燈完成签到,获得积分10
6秒前
雷卿发布了新的文献求助10
7秒前
小森林发布了新的文献求助30
7秒前
7秒前
吴阳完成签到,获得积分10
8秒前
8秒前
8秒前
8秒前
杨三多完成签到,获得积分10
8秒前
乐乐发布了新的文献求助10
8秒前
shirley完成签到,获得积分10
9秒前
9秒前
回音发布了新的文献求助50
9秒前
9秒前
kk发布了新的文献求助10
9秒前
potatoes完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162